V677 mutation of methylenetetrahydrofolate reductase and cardiovascular disease in Canadian Inuit [5]

Lancet

Volumn 349, Issue 9060, 1997, Pages 1221-1222

  Hegele, R A ^a   Tully, C ^a   Young, T K ^a   Connelly, P W ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ADULT; CANADA; CARDIOVASCULAR DISEASE; DIETARY INTAKE; FISH; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INDIAN; LETTER; METHYLATION; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0030938481     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62414-2     Document Type: Article

References (5)

1. TK Young MEK Moffatt JD O'Neil Cardiovascular diseases in a Canadian arctic population Am J Public Health 83 1993 881 887
2. P Frosst HJ Blom R Milos A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
3. LAJ Kluijtmans LPWJ van den Heuvel GHJ Boers Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease Am J Hum Genet 58 1996 35 41
4. RE Stevenson CE Schwartz Y-Z Du MJ Adams Jr Differences in methylenetetrahydrofolate reductase genotype frequencies between blacks and whites Am J Hum Genet 60 1997 229 230
5. ME Moffatt Current status of nutritional deficiencies in Canadian aboriginal people Can J Physiol Pharmacol 73 1995 745 758